India to Peru: Pseudoephedrine Export Trade Route

The India to Peru Pseudoephedrine corridor is one of India's established pharmaceutical export routes, with 3 shipments documented worth a combined $97.3K USD. The route is dominated by HIGLANCE LABORATORIES PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's pseudoephedrine manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $32.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with pseudoephedrine's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 34.5%, placing it at rank #14 among India's top pseudoephedrine export destinations globally.

On the import side, key buyers of Indian pseudoephedrine in Peru include INTIPHARMA S.A.C.. INTIPHARMA S.A.C. is the single largest importer with 3 shipments valued at $97.3K USD.

India's pseudoephedrine exports to Peru are driven primarily by a handful of large-scale manufacturers. HIGLANCE LABORATORIES PRIVATE LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Peru benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — HIGLANCE LABORATORIES PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $32.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as alergizina d (cetirizine hydrochloride 5mg +pseudoephedrine hydrochloride 120mgtablets) b.n.2406082 md.06/24 ed.05/27 and alergizina d (cetirizine hydrochloride 5mg +pseudoephedrine hydrochloride 120mgtab.) b.n.2502037 md.02/2025 ed.01/2028, suggesting that buyers in Peru tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, INTIPHARMA S.A.C. is the largest importer with 3 shipments worth $97.3K USD — representing 100% of all pseudoephedrine imports from India on this route.